[
  {
    "ts": null,
    "headline": "Cardinal Health Inc. stock underperforms Friday when compared to competitors",
    "summary": "Cardinal Health Inc. stock underperforms Friday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=5e7b2d99c7a57b9f81a94061ec9aa2eee12e93ee6c91ada3d4d0899b9a1da6e2",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743785520,
      "headline": "Cardinal Health Inc. stock underperforms Friday when compared to competitors",
      "id": 133858092,
      "image": "",
      "related": "CAH",
      "source": "MarketWatch",
      "summary": "Cardinal Health Inc. stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=5e7b2d99c7a57b9f81a94061ec9aa2eee12e93ee6c91ada3d4d0899b9a1da6e2"
    }
  },
  {
    "ts": null,
    "headline": "Reasons to Add Fresenius Medical Stock to Your Portfolio Now",
    "summary": "FMS continues to gain traction on the back acquisitions & partnerships. A tough regulatory environment raises concerns.",
    "url": "https://finnhub.io/api/news?id=84121b8f240b66f24b63fbf5cd8063d75346daaad32de44b9a69e982b509e486",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743784620,
      "headline": "Reasons to Add Fresenius Medical Stock to Your Portfolio Now",
      "id": 133727377,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "FMS continues to gain traction on the back acquisitions & partnerships. A tough regulatory environment raises concerns.",
      "url": "https://finnhub.io/api/news?id=84121b8f240b66f24b63fbf5cd8063d75346daaad32de44b9a69e982b509e486"
    }
  },
  {
    "ts": null,
    "headline": "SRDX Stock Dips Despite the Launch of Pounce XL Thrombectomy System",
    "summary": "Surmodics launches the Pounce XL Thrombectomy System, aiming to enhance clot removal efficiency, improve patient outcomes, and expand its portfolio of vascular interventions.",
    "url": "https://finnhub.io/api/news?id=f0a67a30afbbc9900df8473b3918add9e7b8edbb61c3da47d7334de4a402e986",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743784560,
      "headline": "SRDX Stock Dips Despite the Launch of Pounce XL Thrombectomy System",
      "id": 133727378,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Surmodics launches the Pounce XL Thrombectomy System, aiming to enhance clot removal efficiency, improve patient outcomes, and expand its portfolio of vascular interventions.",
      "url": "https://finnhub.io/api/news?id=f0a67a30afbbc9900df8473b3918add9e7b8edbb61c3da47d7334de4a402e986"
    }
  },
  {
    "ts": null,
    "headline": "Why Investors Need to Take Advantage of These 2 Medical Stocks Now",
    "summary": "Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.",
    "url": "https://finnhub.io/api/news?id=ecc8cab7645d7eea8eeb75ca603e5f99db7ec3aef5ac9baa4240df17ddd84dff",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743771609,
      "headline": "Why Investors Need to Take Advantage of These 2 Medical Stocks Now",
      "id": 133719772,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.",
      "url": "https://finnhub.io/api/news?id=ecc8cab7645d7eea8eeb75ca603e5f99db7ec3aef5ac9baa4240df17ddd84dff"
    }
  },
  {
    "ts": null,
    "headline": "RMD Stock Benefits From the Launch of NightOwl Across US",
    "summary": "Resmed launches NightOwl, an FDA-cleared home sleep apnea test, in the United States to diagnose OSA at home.",
    "url": "https://finnhub.io/api/news?id=9273381ee49fc4b303dcbf1291d04d31524e5d814807e867cd2fdc0e572fa3c2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743768360,
      "headline": "RMD Stock Benefits From the Launch of NightOwl Across US",
      "id": 133719490,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Resmed launches NightOwl, an FDA-cleared home sleep apnea test, in the United States to diagnose OSA at home.",
      "url": "https://finnhub.io/api/news?id=9273381ee49fc4b303dcbf1291d04d31524e5d814807e867cd2fdc0e572fa3c2"
    }
  }
]